Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anne Mobergslien
Cancer Cell-Binding Peptide Fused Fc Domain Activates Immune Effector Cells and Blocks Tumor Growth
Oncotarget
Oncology
Related publications
HER2-Targeted Hybrid Peptide That Blocks HER2 Tyrosine Kinase Disintegrates Cancer Cell Membrane and Inhibits Tumor Growth in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Tumor-Penetrating Peptide Fused to a Pro-Apoptotic Peptide Facilitates Effective Gastric Cancer Therapy
Oncology Reports
Medicine
Cancer Research
Oncology
Immunoglobulin Fc-Fused Peptide Without CTerminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
Serum IgA Fc Effector Functions in Infectious Disease and Cancer
Immunology and Cell Biology
Allergy
Immunology
Cell Biology
Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
Cancer Research
Cancer Research
Oncology
Transthyretin Stimulates Tumor Growth Through Regulation of Tumor, Immune, and Endothelial Cells
Journal of Immunology
Allergy
Immunology
MicroRNA‑192 Acts as a Tumor Suppressor in Colon Cancer and Simvastatin Activates miR‑192 to Inhibit Cancer Cell Growth
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment
Frontiers in Immunology
Allergy
Immunology
Evolution of Cell-Autonomous Effector Mechanisms in Macrophages Versus Non-Immune Cells
